Welmoed K van Deen1, Arlen Spiro, A Burak Ozbay, Martha Skup, Adriana Centeno, Natalie E Duran, Precious N Lacey, Darius Jatulis, Eric Esrailian, Martijn G H van Oijen, Daniel W Hommes. 1. aCenter for Inflammatory Bowel Diseases, Melvin and Bren Simon Digestive Diseases Center, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles bGehr Family Center for Implementation Science, Division of Geriatric, Hospital, Palliative and General Internal Medicine, Department of Medicine, Keck School of Medicine cLeonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles dAnthem Blue Cross, Woodland Hills, California eAbbVie, North Chicago, Illinois, USA fDepartment of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Abstract
BACKGROUND AND OBJECTIVES: Value-based healthcare (VBHC) is considered to be the solution that will improve quality and decrease costs in healthcare. Many hospitals are implementing programs on the basis of this strategy, but rigorous scientific reports are still lacking. In this pilot study, we present the first-year outcomes of a VBHC program for inflammatory bowel disease (IBD) management that focuses on highly coordinated care, task differentiation of providers, and continuous home monitoring. METHODS: IBD patients treated within the VBHC program were identified in an administrative claims database from a commercial insurer allowing comparisons to matched controls. Only patients for whom data were available the year before and after starting the program were included. Healthcare utilization including visits, hospitalizations, laboratory and imaging tests, and medications were compared between groups. RESULTS: In total, 60 IBD patients treated at the VBHC Center were identified and were matched to 177 controls. Significantly fewer upper endoscopies were performed (-10%, P=0.012), and numerically fewer surgeries (-25%, P=0.49), hospitalizations (-28%, 0=0.71), emergency department visits (-37%, P=0.44), and imaging studies (-25 to -86%) were observed. In addition, 65% fewer patients (P=0.16) used steroids long term. IBD-related costs were 16% ($771) lower than expected (P=0.24). CONCLUSION: These are the first results of a successfully implemented VBHC program for IBD. Encouraging trends toward fewer emergency department visits, hospitalizations, and long-term corticosteroid use were observed. These results will need to be confirmed in a larger sample with more follow-up.
BACKGROUND AND OBJECTIVES: Value-based healthcare (VBHC) is considered to be the solution that will improve quality and decrease costs in healthcare. Many hospitals are implementing programs on the basis of this strategy, but rigorous scientific reports are still lacking. In this pilot study, we present the first-year outcomes of a VBHC program for inflammatory bowel disease (IBD) management that focuses on highly coordinated care, task differentiation of providers, and continuous home monitoring. METHODS: IBD patients treated within the VBHC program were identified in an administrative claims database from a commercial insurer allowing comparisons to matched controls. Only patients for whom data were available the year before and after starting the program were included. Healthcare utilization including visits, hospitalizations, laboratory and imaging tests, and medications were compared between groups. RESULTS: In total, 60 IBD patients treated at the VBHC Center were identified and were matched to 177 controls. Significantly fewer upper endoscopies were performed (-10%, P=0.012), and numerically fewer surgeries (-25%, P=0.49), hospitalizations (-28%, 0=0.71), emergency department visits (-37%, P=0.44), and imaging studies (-25 to -86%) were observed. In addition, 65% fewer patients (P=0.16) used steroids long term. IBD-related costs were 16% ($771) lower than expected (P=0.24). CONCLUSION: These are the first results of a successfully implemented VBHC program for IBD. Encouraging trends toward fewer emergency department visits, hospitalizations, and long-term corticosteroid use were observed. These results will need to be confirmed in a larger sample with more follow-up.
Authors: Miguel Regueiro; Benjamin Click; Alyce Anderson; William Shrank; Jane Kogan; Sandra McAnallen; Eva Szigethy Journal: Clin Gastroenterol Hepatol Date: 2018-04-12 Impact factor: 11.382
Authors: Florence A C J Heijsters; Fenna G F van Breda; Femke van Nassau; Marije K J van der Steen; Piet M Ter Wee; Margriet G Mullender; Martine C de Bruijne Journal: BMC Health Serv Res Date: 2022-04-25 Impact factor: 2.908
Authors: Reinier Cornelis Anthonius van Linschoten; Nikki van Leeuwen; Daan Nieboer; Erwin Birnie; Menne Scherpenzeel; Karen Evelyne Verweij; Vincent de Jonge; Jan Antonius Hazelzet; C Janneke van der Woude; Rachel Louise West; Desirée van Noord Journal: BMJ Open Date: 2022-01-12 Impact factor: 2.692
Authors: Aria Zand; Audrey Nguyen; Courtney Reynolds; Ariela Khandadash; Eric Esrailian; Daniel Hommes Journal: Int J Environ Res Public Health Date: 2021-11-09 Impact factor: 3.390
Authors: Dorine J van Staalduinen; Petra van den Bekerom; Sandra Groeneveld; Martha Kidanemariam; Anne M Stiggelbout; M Elske van den Akker-van Marle Journal: BMC Health Serv Res Date: 2022-03-01 Impact factor: 2.655